Alcoholismo

2'-Fucosyllactose (2'-FL) is the most abundant human milk oligosaccharide (HMO) in the breast milk of most secretor-status mothers, playing a critical role in supporting infant gut microbiota, immune function, and protection during breastfeeding. Clinical trials in formula-fed infants have shown that formula supplemented with 2'-FL closely replicates the bifidogenic, immunological, and gut health benefits of breast milk. It is now produced synthetically and added to infant formulas as a breastfeeding support adjunct.

Algal oil DHA supplementation during breastfeeding increases DHA concentrations in breast milk, ensuring adequate supply of this essential fatty acid to nursing infants. Multiple RCTs confirm this transfer, and expert guidelines recommend 200–300 mg DHA/day for lactating mothers. Algal oil is recognized as a safe, fish-free source for this purpose.

Asparagus racemosus (Shatavari) is a well-known Ayurvedic galactagogue with multiple randomized controlled trials supporting its use for increasing breast milk output. A 2011 double-blind RCT found more than a three-fold increase in prolactin in the treatment group versus controls. A 2025 double-blind placebo-controlled study showed improved breast milk production and maternal satisfaction at 72 hours postpartum. Its primary active constituents are steroidal saponins (Shatavarins) that may mimic estrogen and stimulate prolactin-producing cells.

Beta-carotene is a normal, documented component of human colostrum and mature breast milk, contributing antioxidant defenses to the neonate. Maternal supplementation reliably raises breast milk beta-carotene concentrations, and a systematic review confirmed breastfed infants have higher blood carotenoid levels than formula-fed infants. Some evidence links breast milk beta-carotene to infant motor development.

Topical application of cabbage leaves to the breast is documented across multiple clinical trials and systematic reviews for reducing breast engorgement pain and hardness in lactating women. The NIH LactMed database (NICHD) summarizes this evidence, noting multiple studies found benefit regardless of leaf temperature. A Cochrane review and systematic reviews acknowledge the evidence base, though a meta-analysis found insufficient evidence of superiority over no treatment.

Multiple randomized and controlled studies have examined topical cabbage leaf application for breast engorgement in postpartum women. The evidence shows consistent reductions in breast pain and hardness, though a meta-analysis found no clear advantage over no treatment, as engorgement often resolves spontaneously. One systematic review concluded cold cabbage leaves do reduce breast pain even if engorgement itself may not resolve faster. Despite mixed findings, lactation consultants continue to recommend the intervention widely.

Beta-carotene is a natural constituent of human colostrum and mature breast milk, where it contributes to neonatal antioxidant defenses. Colostrum contains roughly ten times more beta-carotene than mature milk. Maternal dietary intake directly influences milk carotenoid concentrations. The German Nutrition Society recommends a 90% increase in vitamin A intake during lactation, with beta-carotene as a key provitamin A source.

Choline is actively concentrated in breast milk, and demand for it rises significantly during lactation. Maternal supplementation above recommended intake has been shown in controlled trials to increase breast milk choline content. The majority of lactating women do not meet current adequate intake recommendations.

DHA is a critical nutrient during lactation, actively secreted into breast milk and essential for infant neurological and visual development. Maternal DHA supplementation during lactation reliably increases breast milk DHA concentrations and improves infant DHA status. The American Academy of Pediatrics recommends at least 200 mg DHA/day for lactating women.

DHA content in breast milk is directly and positively correlated with maternal DHA intake. Supplementation during lactation reliably increases breast milk DHA concentrations, benefiting infant neurodevelopment and retinal maturation. DHA is considered a critical nutrient during breastfeeding, with international consensus supporting maternal supplementation.

Fenugreek (Trigonella foenum-graecum) is the most widely used herbal galactagogue worldwide, with multiple randomized controlled trials and systematic reviews supporting its use for increasing breast milk supply. A 2020 review of 9 clinical trials found positive effects on breast milk adequacy compared to control groups. Proposed mechanisms include modulation of the insulin/GH/IGF-1 axis and stimulation of oxytocin secretion. Evidence quality varies across studies and some meta-analyses show mixed results.

Folate is naturally present in breast milk and is the primary folate source for exclusively breastfed infants. WHO and MotherToBaby recommend 500 µg/day of folic acid during lactation. Maternal supplementation at typical doses does not substantially alter total milk folate in well-nourished women, but can prevent a postpartum decline in milk folate concentration and leads to the appearance of unmetabolized folic acid in milk. Folate needs during lactation are increased due to its role in DNA, RNA, and protein biosynthesis.

Iodine is actively concentrated in breast milk via the sodium-iodide symporter, making maternal iodine status the primary determinant of infant iodine intake during exclusive breastfeeding. The CDC recommends 290 µg/day for lactating women, higher than the non-pregnant adult RDA of 150 µg/day. Infant thyroid function and neurodevelopment depend directly on the iodine supplied through breast milk. Supplementation of deficient lactating women significantly raises breast milk iodine concentration.

Iron in breast milk is naturally low (~0.35 mg/L), and exclusive breastfeeding may not meet the growing iron requirements of infants, particularly low-birth-weight and preterm babies. The American Academy of Pediatrics advises exclusively breastfed full-term infants start 1 mg/kg/day of iron from four months of age. For lactating mothers, the RDA drops to 9 mg/day (versus 27 mg/day in pregnancy) because menstrual losses cease and recycled maternal red-cell iron partially compensates. Universal iron supplementation of healthy lactating mothers is generally not considered necessary.

L. rhamnosus HN001 administered during pregnancy and continued through breastfeeding was evaluated in a 423-person RCT, reducing postpartum depression and anxiety symptoms in lactating women. LGG administration during lactation has been shown to alter mammary gland and breast milk microbiota in animal models. Separate work supports L. rhamnosus immune modulation in the mammary gland context.

Multiple RCTs demonstrate that L. salivarius strains (particularly PS2 and CECT5713) isolated from human breast milk can treat and prevent lactational mastitis. A large RCT in 328 women found L. salivarius PS2 supplementation from week 35 of pregnancy through 12 weeks postpartum reduced mastitis incidence by 58%. An earlier trial showed oral L. salivarius CECT5713 resolved infectious mastitis by day 14 while mastitis persisted in controls.

Moringa oleifera leaf is a well-researched natural galactagogue used extensively in the Philippines (malunggay) and across Asia. A 2025 systematic review of 8 RCTs found Moringa supplementation significantly increased breast milk volume by up to 400 mL/day and raised serum prolactin by a mean of 231.72 ng/mL compared to controls. A 2026 Bayesian meta-analysis of 14 studies (865 subjects) confirmed a large, clinically meaningful effect size. NIH LactMed cites Moringa as safe with no reported adverse effects in nursing mothers.

DHA from maternal omega-3 intake transfers into breast milk and is important for infant brain and retinal development. Maternal supplementation increases breast milk DHA levels. However, evidence from RCTs that supplementing breastfeeding mothers improves infant cognitive or visual outcomes is inconclusive per Cochrane review.

Red palm oil consumed by lactating mothers significantly increases provitamin A carotenoids in breast milk, improving the vitamin A supply to nursing infants. Clinical studies show this effect surpasses that of β-carotene supplements. This relationship is established in populations at risk of vitamin A deficiency.

Palmitic acid is the most abundant saturated fatty acid in human breast milk, comprising 26–28% of total milk fatty acids, uniquely positioned at the sn-2 carbon of triglycerides. This sn-2 configuration (beta-palmitate) enhances fat and calcium absorption in infants, improves stool consistency, and positively influences the infant gut microbiome. It is a defining structural feature of human milk fat.

Panthenol is commonly used topically on traumatized nipples during breastfeeding. A comparative clinical trial (Shanazi et al., 2015) evaluated dexpanthenol cream against lanolin and peppermint for traumatic nipple treatment in breastfeeding mothers, finding it not superior to comparators. Evidence confirms it is safe during lactation but not established as the most effective nipple treatment.

Serratiopeptidase has been studied specifically for breast engorgement in breastfeeding/postpartum women. A double-blind RCT (Kee et al., Singapore Medical Journal, 1989, n=70) found 85.7% of SRP-treated patients had moderate-to-marked improvement in breast pain, swelling, and induration vs. 60% on placebo (P<0.05). A Cochrane database review also identified it as improving engorgement symptoms.

Thiamine concentrations in breast milk are directly dependent on maternal thiamine intake and status. Infants breastfed by thiamine-deficient mothers are at risk for infantile beriberi. Maternal supplementation corrects low breast-milk thiamine levels in deficient women, with thiamine classified as compatible with breastfeeding by WHO and the American Academy of Pediatrics.

Vitamin B12 is a normal and essential component of human breast milk, required for infant brain development and red blood cell production. Maternal B12 status directly determines milk B12 content and infant B12 status, particularly in exclusively breastfed infants. Mothers following plant-based diets or with absorption disorders are at elevated risk for deficiency with downstream effects on the nursing infant.

Riboflavin requirements increase during lactation because the vitamin is actively secreted into breast milk. Breast milk riboflavin concentration is directly dependent on maternal dietary intake. The RDA rises from 1.1 mg/day to 1.6 mg/day for lactating women. Supplementation is not necessary in well-nourished women but is important where dietary intake is inadequate.

Folate passes into breast milk, and exclusively breastfed infants depend entirely on maternal milk as their folate source. Adequate maternal folate status is essential to meet infant needs and maintain maternal erythrocyte folate. Current recommendations set intake at 500 mcg/day during lactation. Supplementation during lactation has been shown to lower maternal homocysteine and support folate stores.

Ajwain has documented traditional use as a galactagogue (milk-production enhancer) across Ayurvedic, Unani, and folk medicine systems in South Asia and the Middle East. It is commonly given to postpartum women as ajwain-infused water or in ghee-based preparations. No human clinical trials have confirmed this effect.

Alfalfa is a well-recognized traditional galactogogue included in herbal blends promoted for milk production. The NIH LactMed database confirms its traditional use but notes no valid clinical trials support this application. It remains a documented traditional use without scientific validation.

Anise (Pimpinella anisum) is a traditional galactagogue cited in the ABM Clinical Protocol, Cochrane reviews, and La Leche League's list of traditionally used lactogenic herbs. Its anethole content—a phytoestrogen—is proposed to promote milk production by dopamine antagonism and estrogenic activity. No standalone randomized controlled trials support its use; evidence is predominantly ethnomedical. Anise is used as a component in several commercial lactation herbal teas studied in clinical settings.

Ashitaba is documented in traditional Japanese medicine as a galactagogue (milk-production enhancer) for breastfeeding mothers, with dysgalactia (insufficient milk secretion) listed as a traditional indication in the Springer Archives of Pharmacal Research review. No human clinical data on lactation efficacy or safety exist.

Barley (Hordeum vulgare) is a traditional galactagogue used in many cultures to increase breast milk supply. NIH LactMed reports animal evidence that a barley polysaccharide increases serum prolactin, and a double-blind study found that a commercial product containing barley malt, barley glucan, and lemon balm increased milk volume in mothers of preterm infants compared to placebo. The ABM Clinical Protocol also notes that barley components in beer can increase prolactin secretion.

A. scholaris bark is traditionally classified as a galactagogue (lactation promoter) in Ayurvedic, Unani, and folk medicine. It is specifically indicated for agalactia (absence of milk) in nursing mothers. No preclinical or human clinical studies have validated this use pharmacologically.

Blessed thistle (Cnicus benedictus) is a widely used traditional galactagogue commonly recommended alongside fenugreek by lactation specialists. The NIH LactMed database confirms it is included in proprietary lactation products but states no scientifically valid clinical trials support this use. Traditional use is documented in multiple cultures for milk production support. An Australian survey found it rated as slightly to moderately effective by nursing mothers who used it.

Borage has a long-documented traditional use as a galactagogue—an agent to stimulate breast milk production. Leaf infusions and seed preparations have been used for this purpose in European and other herbal traditions. No rigorously controlled clinical trials have confirmed this effect.

Borage has a long traditional use as a galactagogue (lactation promoter) and is documented by MSKCC and other authoritative sources as traditionally used to promote lactation. No clinical RCT evidence for borage oil increasing breast milk production has been identified. Commercial borage oil is actually contraindicated during breastfeeding due to pyrrolizidine alkaloid risk.

Caraway has extensive traditional use as a galactagogue across European, Persian, and Ayurvedic herbal systems, where it is considered one of the most important such agents. NIH LactMed acknowledges this traditional use but notes that no scientifically valid clinical trials support galactagogue efficacy for caraway specifically.

Cumin is traditionally used as a galactagogue (milk-production stimulant) in Iranian, Indian, and other traditional medicine systems, often in tea form. The Drugs.com monograph notes insufficient reliable data on safety and efficacy for lactation. No clinical trials have confirmed this use.

Fennel (Foeniculum vulgare) seeds are a popular traditional galactagogue used across European, Middle Eastern, and Asian cultures. The NIH LactMed database notes two small studies finding increases in milk volume, fat content, and infant weight gain with fennel therapy. Its proposed active constituent, anethole, is a phytoestrogen that may act as a dopamine antagonist to stimulate prolactin secretion. No large, well-controlled randomized trials exist, and excessive use has been linked to toxicity risks.

Garlic (Allium sativum) has been used as a galactagogue in India and Turkey for centuries. NIH LactMed confirms traditional use but states no good scientific data could be located on its use alone as a galactagogue. One pre-experimental study in Indian postnatal mothers found improved breastfeeding adequacy scores after garlic intake, though the design lacked a control group. Notably, garlic odor is transmitted to breast milk, and studies have shown this increases infant suckling time.

Lecithin is widely recommended by lactation consultants and breastfeeding organizations for prevention of recurrent plugged milk ducts, based on its emulsifying properties theorized to reduce milk viscosity and stickiness. The NIH LactMed database and multiple lactation authorities confirm this use, but no high-quality clinical trial has evaluated safety or efficacy for this indication.

Milk thistle (Silybum marianum) is a traditional galactagogue included in proprietary lactation supplements. The NIH LactMed database notes that while no scientifically valid clinical trials support milk thistle itself as a galactagogue, a purified silymarin formulation with phosphatidylserine and goat's rue produced a large increase in milk volume on day 4 postpartum in one study. Animal studies have shown silymarin increases serum prolactin. A double-blind RCT in preterm infants' mothers found no significant milk volume benefit from a silymarin-phosphatidylserine product versus placebo.

Common milkweed (Asclepias syriaca) was traditionally used as a galactagogue—a substance to promote breast milk production—by certain Indigenous North American peoples. This use is recorded in ethnobotanical literature. No clinical evidence supports its efficacy or safety for this purpose, and modern sources note it may be unsafe during breastfeeding.

Momordica charantia is documented as a galactagogue (milk-production promoter) in traditional medicine across South Asia and other tropical regions. However, human clinical evidence is absent, and preclinical studies raise concerns about safety during lactation including abortifacient activity in animal models.

Nettle has a long history of traditional use as a galactagogue (milk-production promoter) across multiple cultures, and it is widely included in commercially available lactation supplement blends. The NIH LactMed database acknowledges the traditional use but notes that only minimal scientific support for a galactagogue effect exists. No scientifically valid clinical trials have confirmed efficacy or safety in nursing mothers.

Parsley is documented in traditional herbalism as an antigalactagogue (milk-reducing agent), used to reduce or cease milk production when weaning. This property is distinct from most herbs in this context. A PMC animal study (2025) confirmed parsley reduced prolactin and milk flow in Merino ewes.

Pituitary substance has a documented traditional role in lactation support, rooted in the gland's production of prolactin — the primary hormone driving milk synthesis. Early 20th-century glandular therapy practitioners included posterior pituitary extracts in obstetric protocols. No modern clinical trials of oral pituitary glandular supplementation for lactation have been conducted.

Sage and related Salvia species have a well-documented traditional use for reducing or suppressing lactation, employed for weaning or overabundant milk supply. The NIH LactMed database confirms this traditional use but notes no clinical trials have evaluated the effect scientifically.

Silybum marianum (milk thistle) has a long-established traditional use as a galactogogue to stimulate milk production. The NIH LactMed database confirms this traditional use but notes no scientifically valid clinical trials support it definitively. A purified silymarin/phosphatidylserine/galega combination product showed some galactogogue activity in one non-randomized study, but quality is insufficient for recommendation.

In several traditional systems across Africa and South America, soursop fruit is used to increase breast milk production after childbirth. This is documented in ethnobotanical literature as a traditional galactagogue application.

Squawvine is documented in folk medicine and traditional herbal practice for improving the flow of breast milk and for topical relief of sore nipples. RxList and encyclopedia sources record these traditional uses. No clinical evidence supports galactagogue or nipple-care efficacy.

Brewer's yeast is widely used traditionally as a galactagogue (milk production stimulant) in North America and Europe. Animal studies demonstrate significant increases in milk yield in ruminants supplemented with S. cerevisiae yeast. However, no human clinical trial has evaluated its efficacy as a galactagogue; evidence is currently limited to anecdote and animal data.